Evidence map›Paper›PMID 33980591›Full record

ArticleJournal of virology2021

Differential Inhibition of HIV Replication by the 12 Interferon Alpha Subtypes.

Alexandra Tauzin, Armando Espinosa Ortiz, Olivia Blake, Calaiselvy Soundaramourty, Charles Joly-Beauparlant, Alexandre Nicolas, Arnaud Droit, Jacques Dutrieux, Jérôme Estaquier, Fabrizio Mammano

Abstract read
In one paragraph

Article in Journal of virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alexandra TauzinINSERM UMR-1124, Paris, France.
Armando Espinosa Ortiz *INSERM UMR-1124, Paris, France.
Olivia Blake *INSERM UMR-941, Paris, France.
Calaiselvy SoundaramourtyINSERM UMR-1124, Paris, France.
Charles Joly-BeauparlantCentre de Recherche du CHU de Québec, Université Laval, Québec, Quebec, Canada.
Alexandre NicolasINSERM UMR-1124, Paris, France.
Arnaud DroitCentre de Recherche du CHU de Québec, Université Laval, Québec, Quebec, Canada.
Jacques DutrieuxINSERM UMR-941, Paris, France.
Jérôme EstaquierINSERM UMR-1124, Paris, France.
Fabrizio MammanoINSERM UMR-1124, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type I interferons (IFNs) are a family of cytokines that represent a first line of defense against virus infections. The 12 different IFN-α subtypes share a receptor on target cells and trigger similar signaling cascades. Several studies have collectively shown that this apparent redundancy conceals qualitatively different responses induced by individual subtypes, which display different efficacies of inhibition of HIV replication. Some studies, however, provided evidence that the disparities are quantitative rather than qualitative. Since RNA expression analyses show a large but incomplete overlap of the genes induced, they may support both models. To explore if the IFN-α subtypes induce functionally relevant different anti-HIV activities, we have compared the efficacies of inhibition of all 12 subtypes on HIV spread and on specific steps of the viral replication cycle, including viral entry, reverse transcription, protein synthesis, and virus release. Finding different hierarchies of inhibition would validate the induction of qualitatively different responses. We found that while most subtypes similarly inhibit virus entry, they display distinctive potencies on other early steps of HIV replication. In addition, only some subtypes were able to target effectively the late steps. The extent of induction of known anti-HIV factors helps to explain some, but not all differences observed, confirming the participation of additional IFN-induced anti-HIV effectors. Our findings support the notion that different IFN-α subtypes can induce the expression of qualitatively different antiviral activities.

Indexed as

Cell LineHEK293 CellsHIV-1HumansImmunity, InnateInterferon-alphaReceptor, Interferon alpha-betaSignal TransductionVirus InternalizationVirus ReplicationInterferon-alphaReceptor, Interferon alpha-betaHIV-1IFN subtypestype I IFNvirus replication

Identifiers

PMID33980591
PMCPMC8274621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.